Silent Spring at 50: Reflections on an Environmental Classic
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Rachel Carson for SILENT SPRING
Silent Spring THE EXPLOSIVE BESTSELLER THE WHOLE WORLD IS TALKING ABOUT RACHEL CARSON Author of THE SEA AROUND US SILENT SPRING, winner of 8 awards*, is the history making bestseller that stunned the world with its terrifying revelation about our contaminated planet. No science- fiction nightmare can equal the power of this authentic and chilling portrait of the un-seen destroyers which have already begun to change the shape of life as we know it. “Silent Spring is a devastating attack on human carelessness, greed and irresponsibility. It should be read by every American who does not want it to be the epitaph of a world not very far beyond us in time.” --- Saturday Review *Awards received by Rachel Carson for SI LENT SPRING: • The Schweitzer Medal (Animal Welfare Institute) • The Constance Lindsay Skinner Achievement Award for merit in the realm of books (Women’s National Book Association) • Award for Distinguished Service (New England Outdoor Writers Association) • Conservation Award for 1962 (Rod and Gun Editors of Metropolitan Manhattan) • Conservationist of the Year (National Wildlife Federation) • 1963 Achievement Award (Albert Einstein College of Medicine --- Women’s Division) • Annual Founders Award (Isaak Walton League) • Citation (International and U.S. Councils of Women) Silent Spring ( By Rachel Carson ) • “I recommend SILENT SPRING above all other books.” --- N. J. Berrill author of MAN’S EMERGING MIND • "Certain to be history-making in its influence upon thought and public policy all over the world." --Book-of-the-Month Club News • "Miss Carson is a scientist and is not given to tossing serious charges around carelessly. -
Latest Analytical Requirements to Meet Global Demands in Food Testing
Latest Analytical Requirements to meet Global Demands in Food Testing Kaushik Banerjee, PhD FNAAS FRSC National Referral Laboratory ICAR-National Research Centre for Grapes Pune 412 307, India E-mail: [email protected] SPS_161116 Challenges in residue analysis • Sample variability (matrix) - High sugar to low sugar - High fat to low fat - High to low water contents • Diverse physico-chemical properties of the target compounds Expectations • high throughput analysis • As many number of analytes as possible • Low levels (<10 ng/g ) • Balancing the performance, cost and speed of analysis SPS_161116 Residue analysis: Compliance to global Regulations Food Market Export Domestic National EUR authorities - Lex European Union eur-lex.europa.eu MHLW Japan http://www.ffcr.or.jp/zaidan/FFCRHOME.nsf/TrueMainE?O penFrameset USFDA USA National www.fda.gov/ authorities AVA Singapore & Malaysia http://www.ava.gov.sg/ SFDA Middle East http://old.sfda.gov.sa/En/Food SPS_161116 Why so much diversity? Food safety concerns are different in different countries There are differences in how food is grown, prepared and consumed across different countries or even within a country Codex standards are generally acceptable Variation in risk incidences Countries may therefore have differing standards. Method sensitivity requirements could vary with regulations SPS_161116 WHY CHEMICAL RESIDUE MONITORING IS INCREASINGLY BECOMING SO IMPORTANT IN ASIAN COUNTRIES? AAU_181016 World map of non- compliance for EU- MRL AAU_181016 EU Alert notifications- trend AAU_181016 Diversified -
Rapid Rise in Toxic Load for Bees Revealed by Analysis of Pesticide Use in Great Britain
A peer-reviewed version of this preprint was published in PeerJ on 19 July 2018. View the peer-reviewed version (peerj.com/articles/5255), which is the preferred citable publication unless you specifically need to cite this preprint. Goulson D, Thompson J, Croombs A. 2018. Rapid rise in toxic load for bees revealed by analysis of pesticide use in Great Britain. PeerJ 6:e5255 https://doi.org/10.7717/peerj.5255 Rapid rise in toxic load for bees revealed by analysis of pesticide use in Great Britain Dave Goulson Corresp., 1 , Jack Thompson 1 , Amy Croombs 1 1 School of Life Sciences, University of Sussex, University of Sussex, Falmer, E Sussex, United Kingdom Corresponding Author: Dave Goulson Email address: [email protected] A strong argument can be made that the European Union has the most rigorous regulatory system for pesticides in the world, and that modern pesticide use poses fewer environmental threats than older regimes. Nevertheless, the impacts of pesticides on bees and other non-target organisms is much debated in Europe as elsewhere. Here we document changing patterns of pesticide use in arable and horticultural crops in Great Britain from 1990 to 2015. The weight of pesticides used has approximately halved over this period, but in contrast the number of applications per field nearly doubled. The total potential kill of honeybees (the total number of LD50 doses applied to the 4.6 million hectares of arable farmland in Great Britain each year) increased six-fold to approximately 3 x 1016 bees, the result of the increasing use of neonicotinoids from 1994 onwards which more than offset the effect of declining organophosphate use. -
Virtual Mentor American Medical Association Journal of Ethics July 2001, Volume 3, Number 7: 252-254
Virtual Mentor American Medical Association Journal of Ethics July 2001, Volume 3, Number 7: 252-254. VIEWPOINT Protecting the Public: Profile of Dr. Frances Oldham Kelsey Karen Geraghty That Dr. Frances Oldham Kelsey saved countless lives and prevented numerous physical deformities of infants and children is a remarkable accomplishment in any career. More remarkable still is the fact that she accomplished this feat not through the discovery of a cure, the development of an innovative surgical procedure, or the invention of a life-saving device. Rather, it was Dr. Kelsey's professional behavior—her unwillingness to compromise the priorities of patient health and safety—that single-handedly averted an appalling tragedy nearly thrust upon an unsuspecting American public. In September 1960, Dr. Kelsey was a newly appointed member of the Food and Drug Administration (FDA). Her very first assignment was to review the application for the drug Kevadon. Synthesized in 1954 and introduced to the market on October 1, 1957 in West Germany, the drug—known there by the name Thalidomide—was hailed as a wonder cure for insomnia. Non-addictive and non- toxic, Thalidomide induced sleep and was prescribed as a sedative that promised no side effects. As its popularity grew, it soon became the drug of choice prescribed to pregnant women combating symptoms associated with morning sickness. By 1960, Thalidomide was popularly prescribed throughout the world, including Europe and Canada. The application by the Richardson-Merrell pharmaceutical company of Cincinnati to introduce Thalidomide under the brand name Kevadon to the US market reached the desk of Dr. Kelsey less than one month after her appointment to the FDA. -
Silent Spring Seemed Unlikely to Manage That
COMMENT BOOKS & ARTS bald eagle (Haliaeetus leucocephalus), were becoming rare. Faced with such observations, Carson began to type, marshalling her own soft voice on behalf of the birds. She found her- self considering society’s choices more gen- erally, writing: “The road we have long been traveling is deceptively easy, a smooth super- highway on which we progress with great speed, but at its end lies disaster.” Seeing that the urge for progress at any cost was driving LIFE PICTURES/GETTY A. EISENSTAEDT//TIME choices about nature, she gave eloquent vent to anger, criticizing indiscriminate spraying with non-selective pesticides that have “the power to kill every insect, the ‘good’ and the ‘bad’, to still the song of birds and the leaping of fish in the streams, to coat the leaves with a deadly film, and to linger on in soil”. Carson’s intent was to trigger change, but on the face of it, Silent Spring seemed unlikely to manage that. It was a beautiful book written by a scientist at a time when scientists were not ‘supposed to’ write beauti- ful books. It was about pesticides, chemistry and society — by a researcher who studied fish. And it concerned the perils of excessive use of pesticides at a time when pesticides were widely believed to be part of the pro- gress of civilization. Yet Silent Spring did not sit quietly. First Rachel Carson launched a global environmental movement with her 1962 call to regulate DDT use. serialized in The New Yorker starting on 16 June 1962, then published in book form, it ignited a flame that raged, bookshelf to book- shelf, around the world. -
Circumpolar Legislation on Pollutants: How Effective Is Arctic Governance on Global Environmental Threats?
Circumpolar Legislation on Pollutants: How Effective is Arctic Governance on Global Environmental Threats? Doris Friedrich The protection of the Arctic environment was one of the main motivations for establishing the Arctic Council. In the past, the Arctic nations have played a pivotal role for several agreements on environmental protection, such as the Stockholm Convention, which can be considered as a positive example of Arctic cooperation and targeted action. However, not all Arctic States have ratified the Convention and its amendments, which regularly add pollutants to the scope of the Convention. Thus, the environmental legislation in the Arctic states does not catch up with the scientific findings and recognition of these threats. This paper examines the efforts of the Arctic nations towards circumpolar governance and international legislation on pollutants, as well as the consequences and effectiveness of these efforts. A brief comparison of policy initiatives, in particular through a look at U.S. legislation, will serve as an illustration of the development of Arctic environmental governance over time and shed light on differences between Arctic states. An effective governance on Persistent Organic Pollutants (POPs) requires a precautionary approach and the regular adaptation to emerging chemicals of concern. While national initiatives have achieved some success in reducing the production and use of POPs, a more comprehensive approach encompassing a list of pollutants corresponding to state- of-the-art research within a global legislative framework is needed. Introduction Persistent Organic Pollutants or ‘POPs’ are environmentally persistent toxic chemicals, which take a long time to degrade and are transported over long distances. Due to the environmental conditions, they often end up in the Arctic, where different biota can act as sinks and where they can cause considerable damage to the environment and human health. -
President's Message
Summer/Fall Issue 2014 SOT News President’s Message With summer quickly coming to an end and a new school year almost upon us, it draws my attention to one of the most important services that the Society of Toxicology (SOT) provides to its membership, Continuing Education (CE). The Society provides a variety of mechanisms for members to continue their professional growth and development. I would like to bring to your attention two specific opportunities on the horizon. The first comes from a recent partnership between the US Food and Drug Administration’s (FDA) Center for Food Safety and Applied Nutrition and SOT. Specifically, the US FDA and SOT will collaborate on providing four half- day sessions over the next year on current topics of mutual interest. This series of sessions, termed the “SOT FDA Colloquia on Emerging Toxicological Science Challenges in Food and Ingredient Safety,” will be open for public attendance as well as available for viewing via webcast. The symposia also will be recorded with links available through the SOT website to President view at your convenience. Norbert E. Kaminski The first of four sessions will focus on partially hydrogenated oils (PHO), often referred to as “trans fats.” This first colloquium, which is tentatively scheduled for October 2014, will cover a variety of topics including, but not limited to, the US FDA recent actions on PHO, the chemistry and biochemistry of PHO and related lipids, the clinical effects of PHO including health hazards and benefits, and will conclude with a moderated roundtable discussion with speakers and invited panelists. -
THE REAL DEAL Meet Dean Jane Aiken Wake Forest Jurist | 1 WAKE FOREST JURIST
THE MAGAZINE OF WAKE FOREST LAW 2020 THE REAL DEAL Meet Dean Jane Aiken Wake Forest Jurist | 1 WAKE FOREST JURIST 2020 Volume 50 ON THE COVER Jane Aiken, Dean of Wake Forest University School of Law EXECUTIVE DIRECTOR PHOTOGRAPHY Wake Forest Jurist is published by Jorge Reyna Allen Aycock Wake Forest University School of Ken Bennett Law. All rights reserved. The views EDITORS Bladen Journal expressed herein do not necessarily Stephanie Skordas Shawn Miller (New York Times) reflect those of Wake Forest Univer- Kaitlyn Ruhf (BA ’13, MA ’20) Robert Ross sity School of Law. Kaitlyn Ruhf (BA ’13, MA ’20) ASSOCIATE EDITOR/ART United States Senate Photographic Services SEND CLASS NOTES TO: DIRECTOR [email protected] Holly Swenson WEBSITE or Trevor Hughes Jurist Notes CONTRIBUTORS Matt Nelkin P.O. Box 7205 Michael Breedlove Winston-Salem, NC 27109 or The Jurist Website 2 | law.wfu.edu jurist.law.wfu.edu WAKE FOREST JURIST 4 THE REAL DEAL EFFECTIVE PANDEMIC A FOND 16 IMMEDIATELY 24 PRO-TEMPORE 38 FAREWELL EVENTS 48 FACULTY HIGHLIGHTS 50 CLASS NOTES 54 Wake Forest Jurist | 1 2 | law.wfu.edu A MESSAGE FROM THE DEAN DRAWING ON OUR STRENGTHS, OUR RESILIENCE, AND OUR HOPE When the dust settles, we will likely be looking back on 2020 as a generation-defining year for our communities, our country, and our world. But perhaps it need not be because of the limitations that the virus suddenly imposed upon us, but because of the resilience, ingenuity, speed, and commitment with which we are adapting and rising to meet the momentous challenge being thrust upon us. -
Autobiographical Reflections
AUTOBIOGRAPHICAL REFLECTIONS FRANCES OLDHAM KELSEY, Ph. D., M. D. Early Life and Education 3 Research, Professional Development, and Family in Chicago 13 Medical Teaching, Research, and Practice in South Dakota 33 Coming to FDA and an Introduction to the Drug Approval Process 43 Thalidomide 49 Post-Drug Amendments Reorganizations of New and Investigational Drugs in the Bureau of Medicine 79 Creation and Work of the Division of Scientific Investigations 81 2 1 AUTOBIOGRAPHICAL REFLECTIONS Frances O. Kelsey, Ph. D., M. D. In thinking about my life, I recall a letter I received in 1987 from an eighth grader in Vermillion, South Dakota, and I remember this for two reasons: first, we had lived in Vermillion, and my daughters went to the Jolley School where this girl was an eighth grader. But, second, because she asked me some questions that I did not feel I answered very well at the time she asked them, and I thought I might weave the answers into my reflections. The girl had to give a speech at her school on a woman who had a career in spite of obstacles. She had gotten a little background information on me from the library and seemed to have done a good job. She asked me for a few more facts, but what drew me up short was when she said: "But, most of all, perhaps you could describe how hard it was to be a woman studying science and medicine when most of your classmates were men. Perhaps you could also tell me how frustrating it must have been to find work when most people thought a woman should only be a housewife." So I thought in reflecting on my life and my 1 Editorial note: This was drawn from the following: oral history interviews conducted in 1974, 1991, and 1992; presentation, Founder’s Day, St. -
Five Reasons to Celebrate the Stockholm Convention
GLOBAL 12 FIVE REASONS TO CELEBRATE THE SUCCESSES STOCKHOLM CONVENTION By Miriam Diamond, University of Toronto The Stockholm Convention on Persistent Organic Pollutants (POPs) has spawned many individual successes at local and regional scales. We can also celebrate the totality of successes related to the Stockholm Convention. This synopsis lists five reasons to celebrate the successes of the Stockholm Convention. The first success for celebration is that global leaders came together to act on curbing POPs concentrations. The very fact that as of November 2011 we have 176 Parties to the Convention as a global legally binding instrument is a major feat unto itself. The Stockholm Convention gives legitimacy and a plan of action in response to public and scientific concerns that we are causing long-term contamination of ourselves and our environment. More than words, about USD 1 billion have been spent to implement hazardous chemical and waste cluster agreements. Behind this success lies decades of work by innumerable members of the public, scientists and regulators. Rachel Carson, in her historic book Silent Spring published in 1962, was the first to draw attention to pesticides that had toxic effects beyond those intended. Underlying Carson’s plea to protect birds and wildlife from pesticides was the concept of chemical persistence, whereby a chemical could cause toxicity long after its initial release. Not only was Carson a harbinger of the adverse effects of persistent organic pollutants, but she was thrown into a maelstrom of controversy and demonization by the chemical industry, the results of which were ultimately a move to control POPs. -
Issue Affirmative Approvals of Many Classes of Products Before Primary Generalized Tonic-Clonic Seizures in Children and Adults They Can Be Marketed
6 | GLOBAL CALENDAR DECEMBER 2015 9–10 Sterile Product JANUARY 2016 Manufacturing Facilities: ® 1–2 ISPE DACH Affiliate GAMP 5 Applying the ISPE Baseline 12 Delaware Valley Chapter January Conference Guide and FDA Guidance Program Mannheim, Germany Principles to Design and Philadelphia, Pennsylvania, US Operation (T12) Training 3 ISPE UK Affiliate Plant Tour Tampa, Florida, US 21 ISPE DACH Affiliate Stakeholder and Presentation Management Tredegar, Gwent, UK Facility Project Management Frankfurt, Germany in the Regulated CASA Education Event & Charity Pharmaceutical Industry* 21–22 ISPE DACH Affiliate Stakeholder Event (T26) Training Management: Wie Geht Das? Raleigh–Durham, North Carolina, Tampa, Florida, US Neu-Isenberg, Germany US Applying Quality Risk 23 Delaware Valley Chapter Future San Francisco/Bay Area Chapter Management (QRM) (T42) Cities Competition Evening Meeting Training Philadelphia Location TBD Tampa, Florida, US 25–27 Basic Principles of 4 Delaware Valley Chapter 10 ISPE Italy Affiliate Xmas Computerized Systems Volunteer Day Night & Single Use Technology Compliance Using GAMP® 5, Milan, Italy Including Revised Annex 11 Rocky Mountain Chapter and Part 11 Update Holiday Event Midwest Chapter End of Year (T45) Training Boulder, Colorado, US Dinner Tampa, Florida, US 7–8 Australasia Affiliate Best Boston Area Chapter Industrial 28–29 A GAMP® Approach to Practices in Aseptic Processes Wireless Network Data Integrity, Electronic Melbourne, Victoria, Australia Andover, Massachusetts, US Records and Signatures, and Operation -
Basic Laboratory Methods in a Regulated Environment
Basic Laboratory Methods in a Regulated Environment CLASSROOM ACTIVITY: FRANCES KELSEY AND THALIDOMIDE IN THE UNITED STATES: A CASE STUDY RELATING TO PHARMACEUTICAL REGULATIONS Submitted by Madison Area Technical College Contact Person: Lisa Seidman, Lseidman@matcmadison .edu 1 Bio-Link Courses-in-a-Box Basic Lab Methods Classroom Activities NOTES TO THE INSTRUCTOR The regulation of pharmaceutical/medical products raises a number of significant questions. Should AIDS patients be able to obtain drugs that have not been fully tested for safety or efficacy? Should herbal/nutritional supplements be regulated by the government? How does society balance the potential benefit of new pharmaceuticals against their potential risk? What are the responsibilities of companies to ensure the safety of drugs? This case study explores some of these topical issues through a discussion of a pivotal episode in the history of drug regulation in the United States. In the early 1960s, Dr. Frances Kelsey and her colleagues at the Food and Drug Administration refused to approve the sedative, thalidomide, for use in the U.S.. Thalidomide was later found to cause severe birth defects when taken by pregnant women in Germany, England, and many other countries. This dramatic case captures students’ interest and provides an effective springboard for discussion of pharmaceutical regulation and related scientific, societal, and ethical issues. We have used this case study with beginning technical college students who are preparing for laboratory careers in biotechnology. We anticipate that this material would be quite appropriate for high school students as well. It has been effective in our classroom to have the students read up to Questions 1 and 2, at the end of the section entitled “The Beginning of the Thalidomide Story.” After discussion, the class votes on whether they would have approved the drug, based on its use in Germany and its supposed safety record there.